Puri Michal Nath bought NVCR
March 3, 2026 · Form 4 insider transaction
Puri Michal Nath bought 58,672 shares of NovoCure Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
58,672
Price
$0.00
Total value
N/A
InsiderPuri Michal Nath
RoleOfficer
CompanyNovoCure Limited (NVCR)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after58,672
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.